Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group-Reference-Cited by-同舟云学术

Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group

Published:2007-06 Issue:6 Volume:78 Page:477-486
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Koistinen Pirjo,Räty Riikka,Itälä Maija,Jantunen Esa,Koivunen Elli,Nousiainen Tapio,Pelliniemi Tarja-Terttu,Remes Kari,Ruutu Tapani,Savolainen Eeva-Riitta,Siitonen Timo,Silvennoinen Raija,Volin Liisa,Elonen Erkki,

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2007.00846.x/fullpdf

Reference33 articles.

1. Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

2. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]

3. ACUTE MYELOID LEUKEMIA: TREATMENTOF ADULTS UNDER 60 YEARS

4. Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission

5. Treatment of acute myeloid leukemia: State-of-the-art and future directions

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide AML ‐2003 study by the Finnish Leukemia Group;European Journal of Haematology;2022-06-14

2. Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol – a prospective nationwide study;Infectious Diseases;2017-07-06

3. A comparative study of idarubicin 12 mg/m2 and 8 mg/m2 combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients;OncoTargets and Therapy;2016-02

4. Acquired multidrug resistance in human K562/ADM cells is associated with enhanced autophagy;Toxicology Mechanisms and Methods;2013-10-08

5. Knockdown of MRP4 by lentivirus-mediated siRNA improves sensitivity to adriamycin in adriamycin-resistant acute myeloid leukemia cells;Chinese Science Bulletin;2011-12-02